Your browser doesn't support javascript.
ANCA-associated vasculitis following ChAdOx1 nCoV19 vaccination: case-based review.
Prabhahar, Arun; Naidu, G S R S N K; Chauhan, Prabhat; Sekar, Aravind; Sharma, Aman; Sharma, Alok; Kumar, Asheesh; Nada, Ritambhra; Rathi, Manish; Kohli, Harbir Singh; Ramachandran, Raja.
  • Prabhahar A; Department of Nephology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Naidu GSRSNK; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Chauhan P; Department of Nephology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sekar A; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sharma A; Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sharma A; Dr Lal Pathlabs, New Delhi, India.
  • Kumar A; Department of Nephrology, IGMC, Shimla, India.
  • Nada R; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Rathi M; Department of Nephology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Kohli HS; Department of Nephology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Ramachandran R; Department of Nephology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. drraja1980@gmail.com.
Rheumatol Int ; 42(4): 749-758, 2022 04.
Article in English | MEDLINE | ID: covidwho-1669776
ABSTRACT
For the foreseeable future, vaccines are the cornerstone in the global campaign against the Coronavirus Disease-19 (COVID-19) pandemic. As the number and fatalities due to COVID-19 decline and the lockdown anywise rescinded, we recognize an increase in the incidence of autoimmune disease post-COVID-19 vaccination. However, the causality of the most vaccine-induced side effects is debatable and, at best, limited to a temporal correlation. We herein report a case of a 51-year-old gentleman who developed Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis (AAV) 2 week post-COVID-19 vaccination. The patient responded favorably to oral steroids and rituximab. Additionally, we conducted a case-based review of vaccine-associated AAV describing their clinical manifestations and treatment response of this emerging entity.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / COVID-19 Type of study: Case report / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Rheumatol Int Year: 2022 Document Type: Article Affiliation country: S00296-021-05069-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / COVID-19 Type of study: Case report / Observational study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans / Male / Middle aged Language: English Journal: Rheumatol Int Year: 2022 Document Type: Article Affiliation country: S00296-021-05069-x